Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).
about
Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients.
P2860
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Stem cell transplantation in m ...... n EBMT preceptorship meeting).
@en
type
label
Stem cell transplantation in m ...... n EBMT preceptorship meeting).
@en
prefLabel
Stem cell transplantation in m ...... n EBMT preceptorship meeting).
@en
P2093
P2860
P50
P1433
P1476
Stem cell transplantation in m ...... n EBMT preceptorship meeting).
@en
P2093
Curly Morris
Gösta Gahrton
Laurent Garderet
Mario Boccadoro
Moreno Festuccia
Nicolaus Kröger
Roberto M Lemoli
P2860
P304
P356
10.3109/10428194.2015.1131278
P577
2016-01-06T00:00:00Z